PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer

NCT03166085 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: PU-H71
DRUG: Nab-paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]